The Cell Viability Assays And Consumables Market was valued at USD 2.5 billion in 2024 and is projected to reach USD 5.0 billion by 2034, registering a CAGR of 7.5%. This growth trajectory is underpinned by several factors, including the increasing prevalence of chronic diseases, the rising demand for personalized medicine, and advancements in biotechnology. The growing focus on drug discovery...